Loading...
Moderna reported lower-than-expected Q3 earnings as it continues to restructure the company. However, the company anticipates breaking even in 2026. BioNTech has reduced its 2023 revenue target by €1 billion due to decreased demand for its COVID-19 vaccine. Airbus delivered 71 aircraft in October, up 18% from the same month last year. Beyond Meat has cut its revenue forecast for the second time in three months due to declining demand for its plant-based proteins. The twin brothers behind a major pharmaceutical fortune are reducing their stake in a COVID-19 vaccine maker as demand for the vaccine diminishes. Air New Zealand is experiencing operational disruptions due to issues with certain Pratt & Whitney engines.
Air New Zealand warns of operations impact from Pratt & Whitney engine issue https://t.co/whHfneFvzx https://t.co/fMvj4kAe5t
BioNTech cuts revenue forecast on lower demand for Covid jabs $BNTX https://t.co/NlUJjAR2RU
Air New Zealand said problems with certain Pratt & Whitney engines are forcing it to make schedule changes that could impact services for as long as two years https://t.co/h8TcPKxtFO
Air Lease doubts if Boeing, Airbus can meet annual delivery targets https://t.co/AXJTmyrA1x https://t.co/nBP295NNiK
Embraer maintains 2023 outlook but deliveries seen at low end of guidance https://t.co/pSynjvhgYt https://t.co/cDuRrBouME
The twin brothers behind one of the world’s biggest pharmaceutical fortunes are cutting their major holding in a maker of Covid-19 vaccines as demand for the shot wanes https://t.co/y4qEutoHTt
The twin brothers behind one of the world’s biggest pharmaceutical fortunes are cutting their major holding in a maker of Covid-19 vaccines as demand for the shot wanes https://t.co/XfHRxs0ORe
The twin brothers behind one of the world’s biggest pharmaceutical fortunes are cutting their major holding in a maker of Covid-19 vaccines as demand for the shot wanes https://t.co/X49QiePM5E
Beyond Meat, $BYND, cut its revenue forecast for the second time in three months amid sagging demand for its plant-based proteins, per Bloomberg.
BioNTech cuts 2023 revenue target on reduced prospects for vaccine https://t.co/7HFWSALMUt https://t.co/EYBIIVHjWo
Airbus delivered 71 aircraft in October - sources https://t.co/xqDKoPSKCg https://t.co/RQ91ickJK8
Shares have dropped 36% this year as demand for its coronavirus inoculations has fallen. https://t.co/kVz926GClv
Germany's BioNTech slashes its forecast for this year’s Covid-19 vaccine sale the latest among drugmakers forced to adjust as the world moves on from the pandemic https://t.co/Ljwwx7udTb
🛑 BIONTECH CUTS 2023 REVENUE TARGET ON REDUCED PROSPECTS FOR VACCINE BioNTech has cut its 2023 revenue target by about 1 billion euros ($1.1 billion) on lower demand for the COVID-19 vaccine made with Pfizer but said the impact from write-downs at its U.S. partner was less… https://t.co/dxoWGhKcI1 https://t.co/DBPX0etxem
✈️ AIRBUS DELIVERED 71 AIRCRAFT IN OCTOBER - SOURCES Airbus delivered 71 aircraft in October, industry sources said on Monday, up 18% from the same month last year. https://t.co/7UJWtKOmLz
AIRBUS DELIVERED 71 AIRCRAFT IN OCTOBER - SOURCES
Moderna missed expectations in its Q3 earnings report as it continues rightsizing the company and putting its COVID-19 vaccine windfall to work. But there's good news ahead: The company expects to finally break even in 2026. https://t.co/ulBX7C1kPa